实用肿瘤学杂志 ›› 2012, Vol. 26 ›› Issue (2): 173-177.doi: 10.3969/j.issn.1002-3070.2012.02.017

• 综述 • 上一篇    下一篇

调节性T细胞与恶性肿瘤的过继免疫治疗

刘艳艳1, 王东亮1, 张艳桥1, 2   

  1. 1.哈尔滨医科大学附属第三医院内八科(哈尔滨 150081);
    2.哈尔滨医科大学肿瘤防治研究所
  • 收稿日期:2012-01-16 出版日期:2012-04-28 发布日期:2014-12-03
  • 通讯作者: 张艳桥,E-mail:yanqiaozhang@126.com
  • 作者简介:刘艳艳,女,(1985-),硕士研究生在读,从事消化道肿瘤的化疗、分子靶向治疗及生物治疗研究

Regulatory T Cells in adoptive cell therapy of cancer

LIU Yanyan1,WANG Dongliang1,ZHANG Yanqiao1,2   

  1. 1.Department of Gastrointestinal Medical Oncology,The Third Affiliated Hospital of Harbin Medical University;
    2.Institute of Treatment and Prevention of Tumor of Heilongjiang Province,Harbin 150081
  • Received:2012-01-16 Online:2012-04-28 Published:2014-12-03

摘要: 过继免疫治疗利用自身免疫细胞进行体外扩增培养,然后回输到体内,它通过增强机体免疫力来对抗肿瘤,对肿瘤细胞具有靶向杀伤性作用,是最有可能彻底清除手术或放化疗后残存肿瘤细胞的治疗手段。但是,调节性T细胞(Regulatory T cells,Tregs)在多种恶性肿瘤患者外周血及微环境中普遍存在着比例上调的情况,这不仅会导致机体固有免疫的负性平衡,还会影响过继免疫治疗的疗效,使其不能发挥最大的抗肿瘤作用。通过对Tregs日渐深入的了解,人们已经研究出多种抑制及消除Tregs的治疗策略。

Abstract: Adoptive cell therapy is the best treatment for patients with residual tumor cells after surgery,radiotherapy or chemotherapy,It is to culture immune cells in vitro for expansion and to reinfuse into the patient to fight against and destruct cancer by enhancing the patient's immunity.However,the phenomenon of regulatory T cells(Tregs)was increased in peripheral blood,and tumor micro-environment of cancer patients is prevalence.These cells not only suppress the innate immunity,but also suppress the effect of adoptive cell therapy,which result in no greatest anti-tumor effect.By further understanding of Tregs,people have developed a variety of treatment strategies to eliminate Tregs.

中图分类号: